A Phase Ib/II Randomized Clinical Trial of Oleclumab with or without Durvalumab plus Chemotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma

1. Coveler, A.L.
2. Reilley, M.J.
3. Zalupski, M.
4. Macarulla, T.
5. Fountzilas, C.
6. Ponz-Sarvisé, M.
7. Nagrial, A.
8. Uboha, N.V.
9. Frentzas, S.
10. Overman, M.
11. Noonan, A.
12. Messersmith, W.A.
13. Pavlakis, N.
14. Mettu, N.B.
15. Bisha, I.
16. Wang, Y.
17. Smith, P.
18. Murtomaki, E.
19. Bielska, A.A.
20. Bragulat, V.
21. Cooper, Z.A.
22. Kumar, R.
23. Spigel, D.R.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1158/1078-0432.CCR-24-0499 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus